Genome-wide Meta-analysis Identifies Variants Associated with Platinating Agent Susceptibility Across Populations

by Wheeler, Heather E., Gamazon, Eric R., Stark, Amy L., O’Donnell, Peter H., Gorsic, Lidija K., Huang, R. Stephanie, Cox, Nancy J., Dolan, M. Eileen
Published 2011

Establishment of CYP2D6 Reference Samples by Multiple Validated Genotyping Platforms

by Fang, Hua, Liu, Xiao, Ramírez, Jacqueline, Choudhury, Noura, Kubo, Michiaki, Im, Hae Kyung, Konkashbaev, Anuar, Cox, Nancy J., Ratain, Mark J., Nakamura, Yusuke, O’Donnell, Peter H.
Published 2014

A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Co...

by Ward, James E., Karrison, Theodore, Chatta, Gurkamal, Hussain, Maha, Shevrin, Daniel, Szmulewitz, Russell Z., O’Donnell, Peter H., Stadler, Walter M., Posadas, Edwin M.
Published 2011

Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients

by Morrison, Gladys, Lenkala, Divya, LaCroix, Bonnie, Ziliak, Dana, Abramson, Vandana, Morrow, Phuong Khanh, Forero, Andres, Van Poznak, Catherine, Rugo, Hope S, Nanda, Rita, O'Donnell, Peter H., Huang, R. Stephanie
Published 2016

Implementing genomic medicine in the clinic: the future is here

by Manolio, Teri A., Chisholm, Rex L., Ozenberger, Brad, Roden, Dan M., Williams, Marc S., Wilson, Richard, Bick, David, Bottinger, Erwin P., Brilliant, Murray H., Eng, Charis, Frazer, Kelly A., Korf, Bruce, Ledbetter, David H., Lupski, James R., Marsh, Clay, Mrazek, David, Murray, Michael F., O'Donnell, Peter H., Rader, Daniel J., Relling, Mary V., Shuldiner, Alan R., Valle, David, Weinshilboum, Richard, Green, Eric D., Ginsburg, Geoffrey S.
Published 2013